Skip to main content
Journal cover image

Lung cancer screening patient-provider discussion: Where do we stand and what are the associated factors?

Publication ,  Journal Article
Chalian, H; Khoshpouri, P; Iranmanesh, AM; Mammarappallil, JG; Assari, S
Published in: SAGE Open Med
2019

OBJECTIVE: The primary objective of this study was to estimate the percentage of individuals possibly eligible for lung cancer screening that report having discussed screening with a health care provider. The secondary objective was to investigate the associated factors of having patient-provider lung cancer screening discussion. METHODS: Data from the Health Information National Trends Survey 2017 were used (n = 3217). Lung cancer screening eligibility was based on the criteria utilized by the Centers for Medicare and Medicaid Services. Gender, race, educational attainment, health insurance coverage, and usual source of health care were covariates. Current or former smokers ages 55-77 (n = 706) were considered potentially eligible for lung cancer screening (dependent variable). RESULTS: Only 12.24% of individuals potentially eligible for lung cancer screening report prior discussion regarding lung cancer screening with a health care provider. Being eligible for lung cancer screening based on Centers for Medicare and Medicaid Services eligibility criteria was positively associated with the odds of a patient-provider lung cancer screening discussion (odds ratio = 3.95, 95% confidence interval = 2.48-6.30). Unlike gender, race, education, or insurance coverage, a usual source of health care was positively associated with a patient-provider screening discussion (odds ratio = 2.48, 95% confidence interval = 1.31-4.70). CONCLUSION: Individuals potentially eligible for lung cancer screening are more likely to have screening discussions with a health care provider. Having a usual source of health care may increase the odds of such a discussion, while patients are not discriminated based on race, gender, education, and insurance coverage. However, the relatively low rate (12.24%) of reported patient-provider lung cancer screening discussion indicates that significant barriers still remain.

Duke Scholars

Published In

SAGE Open Med

DOI

ISSN

2050-3121

Publication Date

2019

Volume

7

Start / End Page

2050312119854265

Location

England

Related Subject Headings

  • 42 Health sciences
  • 32 Biomedical and clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chalian, H., Khoshpouri, P., Iranmanesh, A. M., Mammarappallil, J. G., & Assari, S. (2019). Lung cancer screening patient-provider discussion: Where do we stand and what are the associated factors? SAGE Open Med, 7, 2050312119854265. https://doi.org/10.1177/2050312119854265
Chalian, Hamid, Pegah Khoshpouri, Arya M. Iranmanesh, Joseph G. Mammarappallil, and Shervin Assari. “Lung cancer screening patient-provider discussion: Where do we stand and what are the associated factors?SAGE Open Med 7 (2019): 2050312119854265. https://doi.org/10.1177/2050312119854265.
Chalian H, Khoshpouri P, Iranmanesh AM, Mammarappallil JG, Assari S. Lung cancer screening patient-provider discussion: Where do we stand and what are the associated factors? SAGE Open Med. 2019;7:2050312119854265.
Chalian, Hamid, et al. “Lung cancer screening patient-provider discussion: Where do we stand and what are the associated factors?SAGE Open Med, vol. 7, 2019, p. 2050312119854265. Pubmed, doi:10.1177/2050312119854265.
Chalian H, Khoshpouri P, Iranmanesh AM, Mammarappallil JG, Assari S. Lung cancer screening patient-provider discussion: Where do we stand and what are the associated factors? SAGE Open Med. 2019;7:2050312119854265.
Journal cover image

Published In

SAGE Open Med

DOI

ISSN

2050-3121

Publication Date

2019

Volume

7

Start / End Page

2050312119854265

Location

England

Related Subject Headings

  • 42 Health sciences
  • 32 Biomedical and clinical sciences